<DOC>
	<DOCNO>NCT02608307</DOCNO>
	<brief_summary>In set progressive recurrent cancer , adolescent young adult ( AYA ) patient , parent , healthcare provider ( HCP ) face multiple therapeutic option . Each treatment option unique risk/benefit ratio , result need trade one desirable outcome another accept acute toxicity treatment-related morbidity increase chance survival . Adding complexity decision , stake holder characterize value risk/benefit ratio differently . This study seek learn thing important adolescent young adult cancer , parent , health care provider make decision treatment choice . PRIMARY OBJECTIVE : To quantify relative importance various factor believe important adolescent young adult patient cancer , parent , health care provider choose treatment option hypothetical situation progressive refractory disease .</brief_summary>
	<brief_title>Medical Treatment Decision Making Using Adaptive Conjoint Analysis</brief_title>
	<detailed_description>Data observational study collect first time participant enroll study . If participant agree re-contacted event disease relapse recurrent cancer , follow-up data collect second time point five year enrollment . This second follow-up time point optional . Participants complete two short survey , guide survey laptop computer , interviewer-led interview session . The survey Herth Hope Index ( HHI ) ass hope adult clinical setting , Decision Making Preference Questionnaire ( DMPQ ) identify factor parent believe influence role treatment decision making . The guided survey present hypothetical situation outline different treatment option time recurrent progressive disease . Participants ask answer question related type treatment , location treatment , symptoms side effect treatment , quality life , chance unplanned hospitalization , chance cure , survival length time . Data analyze group : ( 1 ) adolescent young adult patient , ( 2 ) parent , ( 3 ) health-care provider .</detailed_description>
	<criteria>Participants must English speaking . There three main participant subset first time point study : AYA patient ( aged 1330 ) oncological diagnosis currently receive active treatment St. Jude Children 's Research Hospital include least chemotherapy , least three month . Parents patient ( &lt; 18 ) meet criteria . If available , parent young adult patient ( â‰¥18 ) meet criterion invite participate . HCPs patient St. Jude least 1 year experience take care AYA oncology patient . HCPs must MD DO degree attend physician clinical fellow St. Jude Children 's Research Hospital . Patient participant must oncological diagnosis confers less 75 % overall survival base consultation oncologist . Participants agree recontacted five year later , consider take part T2 time point , must participate T1 time point patient participant must relapse recurrent disease time contact , document medical record . Patients relapse recurrent disease time initial enrollment . Patients receive local radiation treatment without adjunctive chemotherapy . Patients parent unable complete study due ill health , cognitive compromise , concern potential distress base consultation psychosocial provider .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Treatment Decision-Making</keyword>
	<keyword>Adolescents Young Adult Oncology</keyword>
</DOC>